Condition
Misoprostol Allergy
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
P 2 (1)
P 4 (2)
Trial Status
Unknown3
Clinical Trials (3)
Showing 3 of 3 trials
NCT05928871Phase 4UnknownPrimary
Pre Versus Post-operative Misoprostol in Reducing Blood Loss After Cesarean Section
NCT05806307Phase 4UnknownPrimary
Methods Decreasing Bleeding in Open Myomectomy
NCT03276000Phase 2UnknownPrimary
Misoprostol for Cervical Priming Before Office Hysteroscopy
Showing all 3 trials